Radioimmunoassay Market Snapshot

The global radioimmunoassay market was valued at US$ 433.9 Million in 2022 and is expected to reach US$ 690.8 Million by 2033. The clinical use segment with a market share more than 82.0% has topped the global market within the purpose category and is expected to grow at a CAGR of close to 3.8% over the forecast period (2023 to 2033)

Market Outlook:

Data Points Market Insights
Market Value 2022 US$ 433.9 Million
Market Value 2023 US$ 451.0 Million
Market Value 2033 US$ 690.8 Million
CAGR 2023 to 2033 4.4%
Market Share of Top 5 Countries 57.7%
Key Market Players PerkinElmer Inc., Berthold Technologies GmbH & Co.KG, LKB Instruments, Montreal Biotech, DIAsource, Abbexa, IBL International GmbH, Creative Biolabs, MP BIOMEDICALS, ALPCO, Padyab Teb Co., Merck KGaA, NovoLytiX GmbH, Beckman Coulter, Inc., DiaSorin S.p.A., DRG INSTRUMENTS GMBH, and EUROIMMUN Medizinische Labordiagnostika AG.

The foundation of radioimmunoassay (RIA) is the formation of antigen-antibody complexes as a result of the competition between labelled and unlabelled antigens for certain antibody sites. Radioimmunoassay is an extremely sensitive method for measuring antigen quantities without the use of a conventional bioassay. RIA is used to estimate the antigenicity of compounds, either naturally or through chemical modification. Hormones, tumour indicators (peptides, proteins, steroids, etc.), vitamins, medicines, and other substances all can be estimated by using this technique.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of Radioimmunoassay Market from 2012 to 2022 Vs Market Outlook for 2023 to 2033

The historical market for radioimmunoassay was around 1.1% of the overall global immunoassay market US$ 40.2 Billion in 2022. Demographic factor as population size, age, distribution and disease prevalence can influence the RIA market. The aging population is more prone to diseases and needs diagnosis. Technological advancement in kit development can help to provide improved, automated and rapid diagnostic methods. These factors significantly shape the demand, adoption, and growth of the market on a global scale. It is essential for businesses operating in this market to closely monitor and understand these factors to make informed decisions and strategies.

  • It has been demonstrated that patients with Hepatitis B Virus (HBV) infection create a greater financial and health burden on society than other patients. The World Health Organisation (WHO) estimates that 296 million individuals worldwide have HBV chronic infection in 2019, making it one of the most prevalent chronic illnesses globally.

Another major health-related issue is diabetes.

  • Somatostatin content in delta-cell number is reduced in type-2 diabetes, claims research published in the International Journal of Molecular Sciences in 2023.

Somatostatin levels are measured using a radioimmunoassay (RIA) but require a longer duration for the development of results. Scientists have undertaken a task to transform the kit into a straightforward handheld gadget that can be mass-produced in a short period. These major applications of radioimmunoassay technology will boost demand for it globally.

What are the Key Opportunities for the Radioimmunoassay Manufacturers?

The availability and quality of healthcare infrastructure, including hospitals, clinics, and diagnostic centers, can impact the adoption of radioimmunoassay. Regions with well-developed healthcare systems are more likely to embrace and integrate advanced medical technologies.

An opportunity exists for the radioimmunoassay industry due to the growth in cancer, chronic illnesses, infectious diseases, therapeutic drug monitoring, and drug addiction throughout the world as well as its use in the diagnosis of autoimmune diseases, cardiology, and endocrinology. This technology can aid in the early detection, monitoring, and management of these conditions, leading to improved patient outcomes.

Collaborations and partnerships between healthcare providers, research institutions, and technology companies can foster innovation and accelerate the adoption of radioimmunoassay. Joint efforts in research, development, and commercialization can lead to the expansion of market reach and the development of new applications.

  • Based on the suggestions of the Association of Diagnostics Manufacturers of India (ADMI), the Government of India placed a 5% import levy on diagnostic kits for the diagnosis of Hepatitis B and HIV since February 2022.

This initiative has helped local RIA kits manufacturer to develop and promote their products within the country. This provides an opportunity for emerging and local manufacturers to expand in the market.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Factors Restraining the Demand for the Radioimmunoassay Market?

The market faces competition from alternative diagnostic technologies such as stable free radicals, fluorochromes, chemiluminescence precursors, enzyme inhibitors, and methods. These are easy to handle, can give qualitative and quantitative information and easy to discard post experiment.

This competition can limit market penetration and slow down the growth of radioimmunoassay, particularly in regions where other technologies are more established. It is largely restricted to immunoassays, the need for expensive reagents and equipment and the requirements for licensing and containment. Another important problem is disposal of radioactive waste management, special training and license required and expensive instrumentation.

Country-wise Insights

Why is the USA a Prominent Market for Radioimmunoassay in North America region?

The USA occupies 29.8% share in global RIA market in the year 2022. The USA has a significant burden of chronic diseases such as obesity, diabetes and cardiovascular diseases. Radioimmunoassay is used in the assessing and managing of these conditions, making it relevant and in demand within the USA healthcare system. The USA has a competitive medical device market, with various manufacturers and suppliers offering radioimmunoassay kit and related products. The demand for radioimmunoassay in the USA market is driven by the need for accurate and invasive diagnostic tools.

What Makes Germany a Highly Lucrative Market for Radioimmunoassay?

The Germany accounts for US$ 38.0 Million in the global market in 2022. Germany boasts a skilled and well-trained healthcare workforce, including physicians, researchers, and technicians. These professionals are knowledgeable in the use and interpretation of radioimmunoassay data, enabling widespread adoption and application of the technology in clinical practice and research. Prominent immunodiagnostic kit developing industries are located in Germany giving it an upper hand in market.

What Makes China a Large Market for Radioimmunoassay?

China held a dominant share of the East Asia market and contributed around US$ 35.8 Million in 2022. The country's swiftly expanding middle class has boosted expenditure on healthcare and disposable money. The need for better-quality healthcare goods, like radioimmunoassay, has increased as a result of demographic shifts. The rising middle class's increased disposable income has helped the Chinese economy expand. The Chinese population is second largest in world making it a huge market for disease diagnostics, RIA being able to identify high level of sensitivity is prominently used for diagnosis many china a large market for radioimmunoassay.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Why Kits & Reagents are Preferred Majorly in Radioimmunoassay Market?

Kits & reagents accounted for US$ 262.9 Million, representing a sizable 60.2% global market share in 2022. The kits and reagents are inexpensive, simple to use, and readily available. They offer great specificity and selectivity, delivering thorough information on biomolecule diagnosis. The compounds are simple to produce and ship as kits, making them readily available. Reagent and kit manufacture takes less time; therefore, they are always ready when needed.

Which Segment Is the Most Lucrative Segment Among Application?

The infectious disease segment accounted for the predominant share in the global market, with a revenue share of 33.5% in 2022. Mutations in bacteria and viruses have increased the prevalence of infectious illnesses in recent years. Bacterial strains that are multi-drug resistant have rapidly developed, and viruses' pathogenicity has increased significantly in parallel. Infectious illness cases have increased as a result, necessitating an immediate and precise diagnosis. Since RIA makes this possible, the segment is the most profitable segment for radioimmunoassay market.

Which End User is Benefiting the Global Market?

The hospitals have a considerable presence in the global market accounting for 27.4% market share in 2022 and expected to grow at a CAGR of 5.4%. When in pain, individuals with and without chronic or infectious disorders visit hospitals. Because nurses and doctors are well-trained and knowledgeable to handle and comprehend these procedures, hospitals are the most beneficial end user in the market.

For What Purpose is Radioimmunoassay Mostly Used?

The clinical use segment contributes US$ 356.6 Million globally in 2022. A significant number of RIA kits are the result of research and development, but their primary function is the detection and identification of a particular molecular target. A vast number of disorders are associated with variations in biomolecule levels. Based on the results of the initial screening, patients are then directed onto RIA, which provides thorough health information. The variety of radioimmunoassay are utilised for clinical purposes since once standardised, an assay does not require further study.

Which Is the Most Prominent Section according to Sample Type in Radioimmunoassay Market?

Serum accounted for US$ 179.6 Million market value in 2022. The sizeable amount of RIAs used to diagnose diseases are carried out on patient serum. Since the serum circulates throughout the body, it contains the most freely floating biomolecules that are present in a person. Serum is easily available, has high amount of antigen, and can be used for multiple test other than RIA, hence it is preferred over saliva, urine, plasma and cell culture sample.

Competitive Landscape

The market for radioimmunoassay is fragmented in nature with numerous prominent firms competing in the market. Collaborations and agreements between healthcare providers, research institutions, and tech companies can spur innovation and speed up the spread of radioimmunoassay. Investment in research and development with commercialization of technologically improved products can lead to market expansion. Among the well-known players in this field are:

  • In May 2023, EUROIMMUN has received an in vitro diagnostic regulatory (IVDR) certificate, which allows the business to transfer goods from higher IVD risk classes B and C to the new IVDR. New items in these classes, on the other hand, may now be promoted as IVDR-compliant, gaining customer trust in the goods and kits.
  • In July 2022, a strategic agreement was signed between Svar Life Science and DIAsource ImmunoAssays to transfer the Chromogranin A NeolisaTM (ELISA) product and the portfolio of radioimmunoassays (RIA) to the latter.
  • In May 2021, PerkinElmer purchased Immunodiagnostic Systems Holdings PLC, a company that specialises in in-vitro diagnostics. As a result of the acquisition, PerkinElmer is going to be able to develop their diagnostic business, notably its immunodiagnostics division.

Similarly, recent developments related to the companies in the radioimmunoassay market have been tracked by the team at Future Market Insights, which are available in the full report.

Report Scope as Per Radioimmunoassay Industry Analysis

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2012 to 2022
Market Analysis US$ Million for Value & Units for Volume
Key Regions Covered North America, Latin America, Europe, East Asia, South Asia, Middle East and Africa (MEA)
Key Countries Covered USA, Canada, Brazil, Mexico, Argentina, Germany, France, Spain, Russia, Italy, BENELUX, UK, India, Indonesia, Thailand, Philippines, Malaysia, Vietnam, China, Japan, South Korea, Australia, New Zealand, GCC countries, Türkiye, South Africa and Northern Africa.
Key Market Segments Covered Product, Application, Purpose, Sample Type, End User, and Region
Key Companies Profiled
  • PerkinElmer Inc.
  • Berthold Technologies GmbH & Co.KG
  • LKB Instruments
  • Montreal Biotech
  • DIAsource
  • IBL International GmbH
  • Creative Biolabs
  • MP BIOMEDICALS
  • ALPCO
  • Padyab Teb Co.
  • Merck KGaA
  • NovoLytiX GmbH
  • Beckman Coulter, Inc.
  • DiaSorin S.p.A.
  • DRG INSTRUMENTS GMBH
  • EUROIMMUN Medizinische Labordiagnostika AG
Report Coverage
  • Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Pricing Available upon Request

Key Market Segments Covered in the Radioimmunoassay Industry Research

By Product:

  • Kits & Reagents
    • Kits
    • Antibodies
  • Instruments
  • Consumables
  • Services

By Application:

  • Oncology
  • Cardiology
  • Endocrinology
  • Infectious Disease
  • Autoimmune Disease
  • Therapeutic Drug Monitoring
  • Drug of Abuse
  • Others

By End User:

  • Hospital
  • Specialty Clinics
  • Academic and Research Institute
  • Diagnostics Laboratories
  • Reference Laboratories
  • Cancer Research Institutes
  • Veterinary Hospitals

By Purpose:

  • Research Use Only
  • Clinical Use

By Sample Type:

  • Serum
  • Plasma
  • Urine
  • Saliva
  • Cell Culture Sample

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

What is Current Market Valuation?

The market is estimated to secure a valuation of US$ 451.0 million in 2023.

What is the Projected Size of the Market by 2033?

The global market size is expected to reach US$ 690.8 million by 2033.

What is the Growth Potential of the Market?

The growth potential of the market is 4.4% through 2033.

What is the Market Share of Top Five Countries?

The market share of top five countries is 57.7%.

What are the types of RIA?

There are two types of RIA, including coated-tube RIA and double-antibody RIA.

Table of Content
1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply-Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Value-Added Insights

    4.1. Product Adoption Analysis

    4.2. Product USPs/Features Analysis

    4.3. Regulatory Landscape, By Country

    4.4. Disease Epidemiology, By Key Indication

    4.5. Porter’s Analysis

    4.6. PESTLE Analysis

    4.7. Value Chain Analysis

    4.8. Unmet Needs Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global Healthcare Expenditure Outlook

        5.1.2. Global Life Science Market Outlook

        5.1.3. Global Immunoassay Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Rising Cases of Chronic Illness

        5.2.2. Increase in Research and Development

        5.2.3. Government Initiative for Early Diagnosis

        5.2.4. Growth of Clinical Diagnostics

        5.2.5. Technological Advancements

        5.2.6. Cost of Product

        5.2.7. Adoption Rate

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. Global Market Demand Volume (Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033

    6.1. Historical Market Volume (Units) Analysis, 2012 to 2022

    6.2. Current and Future Market Volume (Units) Analysis and Forecast Projections, 2023 to 2033

        6.2.1. Y-o-Y Growth Trend Analysis

7. Global Market - Pricing Analysis

    7.1. Regional Pricing Analysis By Product

    7.2. Global Average Pricing Analysis Benchmark

    7.3. Pricing Assumptions

8. Global Market Demand (in Value or Size in US$ Million) Analysis 2012 to 2022 and Forecast, 2023 to 2033

    8.1. Historical Market Value (US$ Million) Analysis, 2012 to 2022

    8.2. Current and Future Market Size (US$ Million) Analysis and Forecast Projections, 2023 to 2033

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

    8.3. Revenue Opportunity Scenario- Likely/Conservative/Optimistic

9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) and Volume (Units) By Product, 2012 to 2022

    9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033

        9.3.1. Kits and Reagents

            9.3.1.1. Kits

            9.3.1.2. Antibodies

        9.3.2. Instruments

        9.3.3. Consumables

        9.3.4. Services

    9.4. Market Attractiveness Analysis By Product

10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Application

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) Analysis By Application, 2012 to 2022

    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033

        10.3.1. Oncology

        10.3.2. Cardiology

        10.3.3. Endocrinology

        10.3.4. Infectious Disease

        10.3.5. Autoimmune Disease

        10.3.6. Therapeutic Drug Monitoring

        10.3.7. Drug of Abuse

        10.3.8. Others

    10.4. Market Attractiveness Analysis By Application

11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Purpose

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million) Analysis By Purpose, 2012 to 2022

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Purpose, 2023 to 2033

        11.3.1. Research Use Only

        11.3.2. Clinical Use

    11.4. Market Attractiveness Analysis By Purpose

12. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Sample Type

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Million) Analysis By Sample Type, 2012 to 2022

    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Sample Type, 2023 to 2033

        12.3.1. Serum

        12.3.2. Plasma

        12.3.3. Urine

        12.3.4. Saliva

        12.3.5. Cell Culture Sample

    12.4. Market Attractiveness Analysis By Sample Type

13. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Million) Analysis By End User, 2012 to 2022

    13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        13.3.1. Hospital

        13.3.2. Specialty Clinics

        13.3.3. Academic and Research Institute

        13.3.4. Diagnostics Laboratories

        13.3.5. Reference Laboratories

        13.3.6. Cancer Research Institutes

        13.3.7. Veterinary Hospitals

    13.4. Market Attractiveness Analysis By End User

14. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2012 to 2022

    14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis Forecast By Region, 2023 to 2033

        14.3.1. North America

        14.3.2. Latin America

        14.3.3. Europe

        14.3.4. South Asia

        14.3.5. East Asia

        14.3.6. Oceania

        14.3.7. Middle East and Africa

    14.4. Market Attractiveness Analysis By Region

15. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    15.1. Introduction / Key Findings

    15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2012 to 2022

    15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        15.3.1. By Country

            15.3.1.1. USA

            15.3.1.2. Canada

        15.3.2. By Product

        15.3.3. By Application

        15.3.4. By Purpose

        15.3.5. By Sample Type

        15.3.6. By End User

    15.4. Market Attractiveness Analysis By Region

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By Application

        15.4.4. By Purpose

        15.4.5. By Sample Type

        15.4.6. By End User

    15.5. Market trends

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

    15.8. Country Level Analysis & Forecast

        15.8.1. USA Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast by Market Taxonomy

                15.8.1.2.1. By Product

                15.8.1.2.2. By Application

                15.8.1.2.3. By Purpose

                15.8.1.2.4. By Sample Type

                15.8.1.2.5. By End User

        15.8.2. Canada Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast by Market Taxonomy

                15.8.2.2.1. By Product

                15.8.2.2.2. By Application

                15.8.2.2.3. By Purpose

                15.8.2.2.4. By Sample Type

                15.8.2.2.5. By End User

16. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    16.1. Introduction / Key Findings

    16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2012 to 2022

    16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        16.3.1. By Country

            16.3.1.1. Brazil

            16.3.1.2. Mexico

            16.3.1.3. Argentina

            16.3.1.4. Rest of Latin America

        16.3.2. By Product

        16.3.3. By Application

        16.3.4. By Purpose

        16.3.5. By Sample Type

        16.3.6. By End User

    16.4. Market Attractiveness Analysis By Region

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By Application

        16.4.4. By Purpose

        16.4.5. By Sample Type

        16.4.6. By End User

    16.5. Market trends

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

    16.8. Country Level Analysis & Forecast

        16.8.1. Brazil Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast by Market Taxonomy

                16.8.1.2.1. By Product

                16.8.1.2.2. By Application

                16.8.1.2.3. By Purpose

                16.8.1.2.4. By Sample Type

                16.8.1.2.5. By End User

        16.8.2. Mexico Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast by Market Taxonomy

                16.8.2.2.1. By Product

                16.8.2.2.2. By Application

                16.8.2.2.3. By Purpose

                16.8.2.2.4. By Sample Type

                16.8.2.2.5. By End User

        16.8.3. Argentina Market Analysis

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast by Market Taxonomy

                16.8.3.2.1. By Product

                16.8.3.2.2. By Application

                16.8.3.2.3. By Purpose

                16.8.3.2.4. By Sample

                16.8.3.2.5. Type By End User

17. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    17.1. Introduction / Key Findings

    17.2. Historical Market Size (US$ Million) Volume (Units) Analysis, By Market Taxonomy, 2012 to 2022

    17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        17.3.1. By Country

            17.3.1.1. Germany

            17.3.1.2. France

            17.3.1.3. Spain

            17.3.1.4. Russia

            17.3.1.5. Italy

            17.3.1.6. BENELUX

            17.3.1.7. UK

            17.3.1.8. Rest of Europe

        17.3.2. By Product

        17.3.3. By Application

        17.3.4. By Purpose

        17.3.5. By Sample Type

        17.3.6. By End User

    17.4. Market Attractiveness Analysis By Region

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By Application

        17.4.4. By Purpose

        17.4.5. By Sample Type

        17.4.6. By End User

    17.5. Market trends

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

    17.8. Country Level Analysis & Forecast

        17.8.1. Germany Market Analysis

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast by Market Taxonomy

                17.8.1.2.1. By Product

                17.8.1.2.2. By Application

                17.8.1.2.3. By Purpose

                17.8.1.2.4. By Sample Type

                17.8.1.2.5. By End User

        17.8.2. France Market Analysis

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast by Market Taxonomy

                17.8.2.2.1. By Product

                17.8.2.2.2. By Application

                17.8.2.2.3. By Purpose

                17.8.2.2.4. By Sample Type

                17.8.2.2.5. By End User

        17.8.3. Spain Market Analysis

            17.8.3.1. Introduction

            17.8.3.2. Market Analysis and Forecast by Market Taxonomy

                17.8.3.2.1. By Product

                17.8.3.2.2. By Application

                17.8.3.2.3. By Purpose

                17.8.3.2.4. By Sample

                17.8.3.2.5. Type By End User

        17.8.4. Russia Market Analysis

            17.8.4.1. Introduction

            17.8.4.2. Market Analysis and Forecast by Market Taxonomy

                17.8.4.2.1. By Product

                17.8.4.2.2. By Application

                17.8.4.2.3. By Purpose

                17.8.4.2.4. By Sample

                17.8.4.2.5. Type By End User

        17.8.5. Italy Market Analysis

            17.8.5.1. Introduction

            17.8.5.2. Market Analysis and Forecast by Market Taxonomy

                17.8.5.2.1. By Product

                17.8.5.2.2. By Application

                17.8.5.2.3. By Purpose

                17.8.5.2.4. By Sample Type

                17.8.5.2.5. By End User

        17.8.6. BENELUX Market Analysis

            17.8.6.1. Introduction

            17.8.6.2. Market Analysis and Forecast by Market Taxonomy

                17.8.6.2.1. By Product

                17.8.6.2.2. By Application

                17.8.6.2.3. By Purpose

                17.8.6.2.4. By Sample Type

                17.8.6.2.5. By End User

        17.8.7. UK Market Analysis

            17.8.7.1. Introduction

            17.8.7.2. Market Analysis and Forecast by Market Taxonomy

                17.8.7.2.1. By Product

                17.8.7.2.2. By Application

                17.8.7.2.3. By Purpose

                17.8.7.2.4. By Sample Type

                17.8.7.2.5. By End User

18. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    18.1. Introduction / Key Findings

    18.2. Historical Market Size (US$ Million) Volume (Units) Analysis, By Market Taxonomy, 2012 to 2022

    18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        18.3.1. By Country

            18.3.1.1. India

            18.3.1.2. Indonesia

            18.3.1.3. Thailand

            18.3.1.4. Philippines

            18.3.1.5. Malaysia

            18.3.1.6. Vietnam

            18.3.1.7. Rest of South Asia

        18.3.2. By Product

        18.3.3. By Application

        18.3.4. By Purpose

        18.3.5. By Sample Type

        18.3.6. By End User

    18.4. Market Attractiveness Analysis By Region

        18.4.1. By Country

        18.4.2. By Product

        18.4.3. By Application

        18.4.4. By Purpose

        18.4.5. By Sample Type

        18.4.6. By End User

    18.5. Market trends

    18.6. Key Market Participants - Intensity Mapping

    18.7. Drivers and Restraints - Impact Analysis

    18.8. Country Level Analysis & Forecast

        18.8.1. India Market Analysis

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast by Market Taxonomy

                18.8.1.2.1. By Product

                18.8.1.2.2. By Application

                18.8.1.2.3. By Purpose

                18.8.1.2.4. By Sample Type

                18.8.1.2.5. By End User

        18.8.2. Indonesia Market Analysis

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast by Market Taxonomy

                18.8.2.2.1. By Product

                18.8.2.2.2. By Application

                18.8.2.2.3. By Purpose

                18.8.2.2.4. By Sample Type

                18.8.2.2.5. By End User

        18.8.3. Thailand Market Analysis

            18.8.3.1. Introduction

            18.8.3.2. Market Analysis and Forecast by Market Taxonomy

                18.8.3.2.1. By Product

                18.8.3.2.2. By Application

                18.8.3.2.3. By Purpose

                18.8.3.2.4. By Sample Type

                18.8.3.2.5. By End User

        18.8.4. Philippines Market Analysis

            18.8.4.1. Introduction

            18.8.4.2. Market Analysis and Forecast by Market Taxonomy

                18.8.4.2.1. By Product

                18.8.4.2.2. By Application

                18.8.4.2.3. By Purpose

                18.8.4.2.4. By Sample Type

                18.8.4.2.5. By End User

        18.8.5. Malaysia Market Analysis

            18.8.5.1. Introduction

            18.8.5.2. Market Analysis and Forecast by Market Taxonomy

                18.8.5.2.1. By Product

                18.8.5.2.2. By Application

                18.8.5.2.3. By Purpose

                18.8.5.2.4. By Sample Type

                18.8.5.2.5. By End User

        18.8.6. Vietnam Market Analysis

            18.8.6.1. Introduction

            18.8.6.2. Market Analysis and Forecast by Market Taxonomy

                18.8.6.2.1. By Product

                18.8.6.2.2. By Application

                18.8.6.2.3. By Purpose

                18.8.6.2.4. By Sample Type

                18.8.6.2.5. By End User

19. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    19.1. Introduction / Key Findings

    19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2012 to 2022

    19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        19.3.1. By Country

            19.3.1.1. China

            19.3.1.2. Japan

            19.3.1.3. South Korea

        19.3.2. By Product

        19.3.3. By Application

        19.3.4. By Purpose

        19.3.5. By Sample Type

        19.3.6. By End User

    19.4. Market Attractiveness Analysis By Region

        19.4.1. By Country

        19.4.2. By Product

        19.4.3. By Application

        19.4.4. By Purpose

        19.4.5. By Sample Type

        19.4.6. By End User

    19.5. Market trends

    19.6. Key Market Participants - Intensity Mapping

    19.7. Drivers and Restraints - Impact Analysis

    19.8. Country Level Analysis & Forecast

        19.8.1. China Market Analysis

            19.8.1.1. Introduction

            19.8.1.2. Market Analysis and Forecast by Market Taxonomy

                19.8.1.2.1. By Product

                19.8.1.2.2. By Application

                19.8.1.2.3. By Purpose

                19.8.1.2.4. By Sample Type

                19.8.1.2.5. By End User

        19.8.2. Japan Market Analysis

            19.8.2.1. Introduction

            19.8.2.2. Market Analysis and Forecast by Market Taxonomy

                19.8.2.2.1. By Product

                19.8.2.2.2. By Application

                19.8.2.2.3. By Purpose

                19.8.2.2.4. By Sample Type

                19.8.2.2.5. By End User

        19.8.3. South Korea Market Analysis

            19.8.3.1. Introduction

            19.8.3.2. Market Analysis and Forecast by Market Taxonomy

                19.8.3.2.1. By Product

                19.8.3.2.2. By Application

                19.8.3.2.3. By Purpose

                19.8.3.2.4. By Sample Type

                19.8.3.2.5. By End User

20. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    20.1. Introduction / Key Findings

    20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2012 to 2022

    20.3. Current and Future Market Size (US$ Million) Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        20.3.1. By Country

            20.3.1.1. Australia

            20.3.1.2. New Zealand

        20.3.2. By Product

        20.3.3. By Application

        20.3.4. By Purpose

        20.3.5. By Sample Type

        20.3.6. By End User

    20.4. Market Attractiveness Analysis By Region

        20.4.1. By Country

        20.4.2. By Product

        20.4.3. By Application

        20.4.4. By Purpose

        20.4.5. By Sample Type

        20.4.6. By End User

    20.5. Market trends

    20.6. Key Market Participants - Intensity Mapping

    20.7. Drivers and Restraints - Impact Analysis

    20.8. Country Level Analysis & Forecast

        20.8.1. Australia Market Analysis

            20.8.1.1. Introduction

            20.8.1.2. Market Analysis and Forecast by Market Taxonomy

                20.8.1.2.1. By Product

                20.8.1.2.2. By Application

                20.8.1.2.3. By Purpose

                20.8.1.2.4. By Sample Type

                20.8.1.2.5. By End User

        20.8.2. New Zealand Market Analysis

            20.8.2.1. Introduction

            20.8.2.2. Market Analysis and Forecast by Market Taxonomy

                20.8.2.2.1. By Product

                20.8.2.2.2. By Application

                20.8.2.2.3. By Purpose

                20.8.2.2.4. By Sample Type

                20.8.2.2.5. By End User

21. Middle East and Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    21.1. Introduction / Key Findings

    21.2. Historical Market Size (US$ Million) Volume (Units) Analysis, By Market Taxonomy, 2012 to 2022

    21.3. Current and Future Market Size (US$ Million) Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        21.3.1. By Country

            21.3.1.1. GCC Countries

            21.3.1.2. Türkiye

            21.3.1.3. South Africa

            21.3.1.4. Northern Africa

            21.3.1.5. Rest of Middle East and Africa

        21.3.2. By Product

        21.3.3. By Application

        21.3.4. By Purpose

        21.3.5. By Sample Type

        21.3.6. By End User

    21.4. Market Attractiveness Analysis By Region

        21.4.1. By Country

        21.4.2. By Product

        21.4.3. By Application

        21.4.4. By Purpose

        21.4.5. By Sample Type

        21.4.6. By End User

    21.5. Market trends

    21.6. Key Market Participants - Intensity Mapping

    21.7. Drivers and Restraints - Impact Analysis

    21.8. Country Level Analysis & Forecast

        21.8.1. GCC Countries Market Analysis

            21.8.1.1. Introduction

            21.8.1.2. Market Analysis and Forecast by Market Taxonomy

                21.8.1.2.1. By Product

                21.8.1.2.2. By Application

                21.8.1.2.3. By Purpose

                21.8.1.2.4. By Sample Type

                21.8.1.2.5. By End User

        21.8.2. Türkiye Market Analysis

            21.8.2.1. Introduction

            21.8.2.2. Market Analysis and Forecast by Market Taxonomy

                21.8.2.2.1. By Product

                21.8.2.2.2. By Application

                21.8.2.2.3. By Purpose

                21.8.2.2.4. By Sample Type

                21.8.2.2.5. By End User

        21.8.3. South Africa Market Analysis

            21.8.3.1. Introduction

            21.8.3.2. Market Analysis and Forecast by Market Taxonomy

                21.8.3.2.1. By Product

                21.8.3.2.2. By Application

                21.8.3.2.3. By Purpose

                21.8.3.2.4. By Sample Type

                21.8.3.2.5. By End User

        21.8.4. Northern Africa Market Analysis

            21.8.4.1. Introduction

            21.8.4.2. Market Analysis and Forecast by Market Taxonomy

                21.8.4.2.1. By Product

                21.8.4.2.2. By Application

                21.8.4.2.3. By Purpose

                21.8.4.2.4. By Sample Type

                21.8.4.2.5. By End User

22. Market Structure Analysis

    22.1. Market Analysis by Tier of Companies

    22.2. Market Share Analysis of Top Players (%)

    22.3. Market Presence Analysis

        22.3.1. Regional Footprint of Players

        22.3.2. Product Footprint of Players

        22.3.3. Channel Footprint of Players

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Key Development Analysis

    23.3. Branding and Promotional Strategies, By Key Players

    23.4. Competition Deep Dive

        23.4.1. PerkinElmer Inc.

            23.4.1.1. Overview

            23.4.1.2. Product Portfolio

            23.4.1.3. Key Financials

            23.4.1.4. Sales Footprint

            23.4.1.5. SWOT Analysis

            23.4.1.6. Strategy Overview

                23.4.1.6.1. Marketing Strategies

                23.4.1.6.2. Channel Strategies

                23.4.1.6.3. Product Strategies

        23.4.2. Berthold Technologies GmbH & Co.KG

            23.4.2.1. Overview

            23.4.2.2. Product Portfolio

            23.4.2.3. Key Financials

            23.4.2.4. Sales Footprint

            23.4.2.5. SWOT Analysis

            23.4.2.6. Strategy Overview

                23.4.2.6.1. Marketing Strategies

                23.4.2.6.2. Channel Strategies

                23.4.2.6.3. Product Strategies

        23.4.3. LKB Instruments

            23.4.3.1. Overview

            23.4.3.2. Product Portfolio

            23.4.3.3. Key Financials

            23.4.3.4. Sales Footprint

            23.4.3.5. SWOT Analysis

            23.4.3.6. Strategy Overview

                23.4.3.6.1. Marketing Strategies

                23.4.3.6.2. Channel Strategies

                23.4.3.6.3. Product Strategies

        23.4.4. Montreal Biotech

            23.4.4.1. Overview

            23.4.4.2. Product Portfolio

            23.4.4.3. Key Financials

            23.4.4.4. Sales Footprint

            23.4.4.5. SWOT Analysis

            23.4.4.6. Strategy Overview

                23.4.4.6.1. Marketing Strategies

                23.4.4.6.2. Channel Strategies

                23.4.4.6.3. Product Strategies

        23.4.5. DIAsource

            23.4.5.1. Overview

            23.4.5.2. Product Portfolio

            23.4.5.3. Key Financials

            23.4.5.4. Sales Footprint

            23.4.5.5. SWOT Analysis

            23.4.5.6. Strategy Overview

                23.4.5.6.1. Marketing Strategies

                23.4.5.6.2. Channel Strategies

                23.4.5.6.3. Product Strategies

        23.4.6. Abbexa

            23.4.6.1. Overview

            23.4.6.2. Product Portfolio

            23.4.6.3. Key Financials

            23.4.6.4. Sales Footprint

            23.4.6.5. SWOT Analysis

            23.4.6.6. Strategy Overview

                23.4.6.6.1. Marketing Strategies

                23.4.6.6.2. Channel Strategies

                23.4.6.6.3. Product Strategies

        23.4.7. IBL International GmbH

            23.4.7.1. Overview

            23.4.7.2. Product Portfolio

            23.4.7.3. Key Financials

            23.4.7.4. Sales Footprint

            23.4.7.5. SWOT Analysis

            23.4.7.6. Strategy Overview

                23.4.7.6.1. Marketing Strategies

                23.4.7.6.2. Channel Strategies

                23.4.7.6.3. Product Strategies

        23.4.8. Creative Biolabs

            23.4.8.1. Overview

            23.4.8.2. Product Portfolio

            23.4.8.3. Key Financials

            23.4.8.4. Sales Footprint

            23.4.8.5. SWOT Analysis

            23.4.8.6. Strategy Overview

                23.4.8.6.1. Marketing Strategies

                23.4.8.6.2. Channel Strategies

                23.4.8.6.3. Product Strategies

        23.4.9. MP Biomedicals

            23.4.9.1. Overview

            23.4.9.2. Product Portfolio

            23.4.9.3. Key Financials

            23.4.9.4. Sales Footprint

            23.4.9.5. SWOT Analysis

            23.4.9.6. Strategy Overview

                23.4.9.6.1. Marketing Strategies

                23.4.9.6.2. Channel Strategies

                23.4.9.6.3. Product Strategies

        23.4.10. ALPCO

            23.4.10.1. Overview

            23.4.10.2. Product Portfolio

            23.4.10.3. Key Financials

            23.4.10.4. Sales Footprint

            23.4.10.5. SWOT Analysis

            23.4.10.6. Strategy Overview

                23.4.10.6.1. Marketing Strategies

                23.4.10.6.2. Channel Strategies

                23.4.10.6.3. Product Strategies

        23.4.11. Padyab Teb Co.

            23.4.11.1. Overview

            23.4.11.2. Product Portfolio

            23.4.11.3. Key Financials

            23.4.11.4. Sales Footprint

            23.4.11.5. SWOT Analysis

            23.4.11.6. Strategy Overview

                23.4.11.6.1. Marketing Strategies

                23.4.11.6.2. Channel Strategies

                23.4.11.6.3. Product Strategies

        23.4.12. Merck KGaA

            23.4.12.1. Overview

            23.4.12.2. Product Portfolio

            23.4.12.3. Key Financials

            23.4.12.4. Sales Footprint

            23.4.12.5. SWOT Analysis

            23.4.12.6. Strategy Overview

                23.4.12.6.1. Marketing Strategies

                23.4.12.6.2. Channel Strategies

                23.4.12.6.3. Product Strategies

        23.4.13. NovoLytiX GmbH

            23.4.13.1. Overview

            23.4.13.2. Product Portfolio

            23.4.13.3. Key Financials

            23.4.13.4. Sales Footprint

            23.4.13.5. SWOT Analysis

            23.4.13.6. Strategy Overview

                23.4.13.6.1. Marketing Strategies

                23.4.13.6.2. Channel Strategies

                23.4.13.6.3. Product Strategies

        23.4.14. Beckman Coulter, Inc.

            23.4.14.1. Overview

            23.4.14.2. Product Portfolio

            23.4.14.3. Key Financials

            23.4.14.4. Sales Footprint

            23.4.14.5. SWOT Analysis

            23.4.14.6. Strategy Overview

                23.4.14.6.1. Marketing Strategies

                23.4.14.6.2. Channel Strategies

                23.4.14.6.3. Product Strategies

        23.4.15. DiaSorin S.p.A.

            23.4.15.1. Overview

            23.4.15.2. Product Portfolio

            23.4.15.3. Key Financials

            23.4.15.4. Sales Footprint

            23.4.15.5. SWOT Analysis

            23.4.15.6. Strategy Overview

                23.4.15.6.1. Marketing Strategies

                23.4.15.6.2. Channel Strategies

                23.4.15.6.3. Product Strategies

        23.4.16. DRG INSTRUMENTS GMBH

            23.4.16.1. Overview

            23.4.16.2. Product Portfolio

            23.4.16.3. Key Financials

            23.4.16.4. Sales Footprint

            23.4.16.5. SWOT Analysis

            23.4.16.6. Strategy Overview

                23.4.16.6.1. Marketing Strategies

                23.4.16.6.2. Channel Strategies

                23.4.16.6.3. Product Strategies

        23.4.17. EUROIMMUN Medizinische Labordiagnostika AG

            23.4.17.1. Overview

            23.4.17.2. Product Portfolio

            23.4.17.3. Key Financials

            23.4.17.4. Sales Footprint

            23.4.17.5. SWOT Analysis

            23.4.17.6. Strategy Overview

                23.4.17.6.1. Marketing Strategies

                23.4.17.6.2. Channel Strategies

                23.4.17.6.3. Product Strategies

24. Assumptions and Acronyms Used

25. Research Methodology
Recommendations

Healthcare

Fertility and Pregnancy Rapid Test Kit Market

February 2022

REP-GB-607

October 2023

183 pages

Healthcare

Cardiac Biomarker Diagnostic Test Kits Market

December 2021

REP-GB-452

September 2023

239 pages

Healthcare

Respiratory Pathogen Testing Kits Market

June 2020

REP-GB-10542

March 2023

345 pages

Healthcare

Immunoassay Market

August 2022

REP-GB-15437

October 2022

342 pages

Explore Healthcare Insights

View Reports